VSTM Shares Outstanding History



Below is a table of the VSTM shares outstanding history going back to 1/27/2012:

Date VSTM Shares Outstanding
1/27/20121.60M
3/15/20121.75M
5/4/20121.75M
8/10/20121.77M
11/9/20121.77M
2/28/20131.76M
4/30/20131.77M
7/31/20132.13M
11/7/20132.14M
2/28/20142.15M
4/30/20142.15M
7/31/20142.15M
10/23/20142.16M
2/27/20153.00M
5/6/20153.04M
8/5/20153.07M
10/29/20153.08M
2/22/20163.08M
5/2/20163.08M
8/2/20163.08M
10/31/20163.08M
3/15/20173.08M
5/8/20173.08M
8/4/20173.08M
11/6/20173.37M
3/7/20184.23M
8/6/20186.13M
11/2/20186.15M
3/7/20196.16M
5/2/20196.16M
8/1/20196.18M
10/30/20196.20M
3/11/202012.37M
5/6/202013.54M
8/7/202014.13M
11/6/202014.15M
3/17/202114.31M
5/10/202114.33M
7/30/202115.06M
11/3/202115.18M
3/25/202215.53M
5/6/202215.53M
8/5/202215.65M
9/30/202217.51M
3/13/202316.72M
5/8/202316.74M
8/7/202325.25M
11/7/202325.27M

Also see: VSTM Market Cap History
VSTM YTD Return
VSTM Historical Shares Outstanding:
+26.36% CAGR
VSTM Historical Shares Outstanding: +26.36% CAGR

Mouse over chart for data details
1/27/2012 ...11/7/2023
Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors. We show 48 historical shares outstanding datapoints in our coverage of VSTM's shares outstanding history.

Understanding the changing numbers of VSTM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VSTM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VSTM by allowing them to research VSTM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VSTM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Verastem (VSTM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VTGN Shares Outstanding History
VTL Shares Outstanding History
VTRS Shares Outstanding History
VTVT Shares Outstanding History
VTYX Shares Outstanding History
VVOS Shares Outstanding History
VVUS Shares Outstanding History
VXRT Shares Outstanding History
VYGR Shares Outstanding History
VYNE Shares Outstanding History
More Healthcare companies »

 

VSTM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.